Zomedica Corp.
ZOMDF
$0.10
$0.00-1.41%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.39% | 10.20% | 8.74% | 6.00% | 8.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.39% | 10.20% | 8.74% | 6.00% | 8.33% |
| Cost of Revenue | 26.26% | 15.80% | 6.27% | -2.63% | 4.19% |
| Gross Profit | 13.58% | 7.76% | 9.86% | 10.10% | 10.21% |
| SG&A Expenses | -8.14% | -9.75% | -6.61% | -0.18% | 8.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.83% | -6.18% | -3.40% | 0.74% | 9.75% |
| Operating Income | 18.58% | 17.62% | 12.01% | 3.21% | -10.88% |
| Income Before Tax | -72.78% | -36.63% | -47.84% | -161.67% | -32.56% |
| Income Tax Expenses | 50.09% | -331.71% | 83.45% | 73.71% | 58.12% |
| Earnings from Continuing Operations | -74.23% | -35.90% | -51.99% | -172.43% | -36.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.23% | -35.90% | -51.99% | -172.43% | -36.06% |
| EBIT | 18.58% | 17.62% | 12.01% | 3.21% | -10.88% |
| EBITDA | 23.94% | 23.06% | 17.88% | 9.09% | -6.92% |
| EPS Basic | -74.48% | -35.80% | -51.84% | -171.92% | -35.41% |
| Normalized Basic EPS | 16.50% | 15.98% | 9.22% | -1.06% | -19.05% |
| EPS Diluted | -74.48% | -35.80% | -51.84% | -171.92% | -35.41% |
| Normalized Diluted EPS | 16.50% | 15.98% | 9.22% | -1.06% | -19.05% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |